Publications by authors named "Micha Pilz"

Claim this Profile
A
A scoping review of thresholds for responder and time-to-event analysis of patient-reported outcomes in breast cancer trials.
Anna Margarete Maria Thurner, Daniela Krepper, Micha Johannes Pilz, Lisa Marie Storz, Maike Thumfart

Br J Clin Pharmacol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Facilitating the interpretation of the multidimensional EORTC QLQ-FA12 fatigue questionnaire: Establishing thresholds for clinical importance.
Patricia Blickle, Lisa M Storz, Martina E Schmidt, Jens Lehmann, Micha J Pilz

Eur J Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age- and sex-specific reference values for the Banff Patella Instability Instrument (BPII 2.0) in the German population based on 1309 participants.
Felix Zimmermann, Peter Balcarek, Johannes Maria Giesinger, Micha Johannes Pilz, Michael Liebensteiner

Knee Surg Sports Traumatol Arthrosc· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the Cancer-Specific Preference-Based Measure EORTC QLU-C10D against the Generic Instruments EQ-5D-5L and SF-6Dv2 in a Prospectively Collected Sample of Patients with Cancer in Austria and France.
Micha J Pilz, Simone Seyringer, Virginie Nerich, Madeleine T King, Richard Norman

Pharmacoeconomics· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-specific utility: clinical validation of the EORTC QLU-C10D in patients with glioblastoma.
Simone Seyringer, Micha J Pilz, Andrew Bottomley, Madeleine T King, Richard Norman

Eur J Health Econ· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The current use and application of thresholds for clinical importance of the EORTC QLQ-C30, the EORTC CAT core and the EORTC QLQ-C15-PAL- a systematic scoping review.
Micha J Pilz, Anna M M Thurner, Lisa M Storz, Daniela Krepper, Johannes M Giesinger

Health Qual Life Outcomes· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the cancer-specific utility measure EORTC QLU-C10D using evidence from four lung cancer trials covering six country value sets.
Simone Seyringer, Micha J Pilz, Imad Al-Naesan, Madeleine T King, Andrew Bottomley

Sci Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum to "Cancer-specific utility instrument for health economic evaluations: A synopsis of the EORTC QLU-C10D user manual and current validity evidence" [Eur J Cancer (2025) 115235].
Simone Seyringer, Micha Pilz, Femke Jansen, Matthias Büttner, Madeleine T King

Eur J Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Norwegian and Swedish value sets for the EORTC QLU-C10D utility instrument.
Gudrun Rohde, Jens Lehmann, Micha J Pilz, Leslye Rojas-Concha, Bernhard Holzner

Qual Life Res· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-specific utility instrument for health economic evaluations: A synopsis of the EORTC QLU-C10D user manual and current validity evidence.
Simone Seyringer, Micha Johannes Pilz, Femke Jansen, Matthias Büttner, Madeleine T King

Eur J Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands.
Micha J Pilz, Simon Seyringer, Lára R Hallsson, Andrew Bottomley, Femke Jansen

Eur J Health Econ· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing the contents of patient-reported outcome measures for fatigue: EORTC CAT Core, EORTC QLQ-C30, EORTC QLQ-FA12, FACIT, PRO-CTCAE, PROMIS, Brief Fatigue Inventory, Multidimensional Fatigue Inventory, and Piper Fatigue Scale.
Maria Rothmund, Micha J Pilz, Nathalie Egeter, Emma Lidington, Claire Piccinin

Health Qual Life Outcomes· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cancer-Specific Health Economic Measure QLU-C10D is Valid and Responsive for Assessing Health Utility in Patients with Thyroid Cancer.
Micha J Pilz, Simone Seyringer, Susanne Singer, Georgios Ioannidis, Gerasimos P Sykiotis

Thyroid· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients-Data from Four Multicentre LUX-Lung Trials, Applying Six Country Tariffs.
Micha J Pilz, Simone Seyringer, Imad Al-Naesan, Madeleine T King, Andrew Bottomley

Pharmacoecon Open· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
General population normative values for the EORTC QLQ-C30 by age, sex, and health condition for the French general population.
Micha J Pilz, Fanny L C Loth, Sandra Nolte, Anna M M Thurner, Eva-Maria Gamper

J Patient Rep Outcomes· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Equipercentile equating of scores from common patient-reported outcome measures of physical function in patients with cancer.
Maria Rothmund, Micha J Pilz, Lisa Schlosser, Juan I Arraras, Mogens Groenvold

J Clin Epidemiol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Content comparison of the EORTC CAT Core, SF-36, FACT-G, and PROMIS role and social functioning measures based on the International Classification of Functioning, Disability and Health.
Micha J Pilz, Maria Rothmund, Emma Lidington, Claire Piccinin, Juan I Arraras

Psychooncology· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The European Organisation for Research and Treatment of Cancer Quality of Life Utility-Core 10 Dimensions: Development and Investigation of General Population Utility Norms for Canada, France, Germany, Italy, Poland, and the United Kingdom.
Micha Johannes Pilz, Sandra Nolte, Gregor Liegl, Madeleine King, Richard Norman

Value Health· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcome measures for emotional functioning in cancer patients: Content comparison of the EORTC CAT Core, FACT-G, HADS, SF-36, PRO-CTCAE, and PROMIS instruments.
Maria Rothmund, Micha J Pilz, Nathalie Egeter, Emma Lidington, Claire Piccinin

Psychooncology· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EORTC QLQ-C30 general population normative data for Italy by sex, age and health condition: an analysis of 1,036 individuals.
Micha J Pilz, Eva-Maria Gamper, Fabio Efficace, Juan I Arraras, Sandra Nolte

BMC Public Health· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Thresholds for Clinical Importance of the EORTC QLQ-C15-PAL in Patients Receiving Palliative Treatment.
Micha J Pilz, Neil K Aaronson, Juan I Arraras, Giovanni Caocci, Fabio Efficace

J Palliat Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis